|
|
Prepublished online as a Blood First Edition Paper on February 13, 2003; DOI 10.1182/blood-2002-12-3680.
Previous Article | Table of Contents | Next Article 
Blood, 15 June 2003, Vol. 101, No. 12, pp. 4797-4801
HEMOSTASIS, THROMBOSIS, AND VASCULAR BIOLOGY
Activated protein C alters cytosolic calcium flux in human brain endothelium via binding to endothelial protein C receptor and activation of protease activated receptor-1
Eszter Dömötör,
Omar Benzakour,
John H. Griffin,
David Yule,
Kenji Fukudome, and
Berislav V. Zlokovic
From the Frank P. Smith Neurosurgical Research Laboratory, Department of Neurosurgery and Division of Neurovascular Biology, Center of Aging and Development Biology, University of Rochester Medical Center, Rochester, NY; Department of Molecular and Experimental Medicine, The Scripps Research Institute, La Jolla, CA; Department of Physiology and Pharmacology, University of Rochester Medical Center, Rochester, NY; Department of Immunology, Saga Medical School, Saga, Japan; and Socratech Laboratories, Rochester, NY.
Activated protein C (APC) exerts endothelial protein C receptor (EPCR)dependent neuroprotective effects in a brain focal ischemia model and direct cellular effects on human umbilical vein endothelial cells (HUVECs) via protease-activated receptor-1 (PAR-1). Because PAR receptors are expressed in brain endothelium and mediate intracellular calcium concentration ([Ca2+]i) signaling, we hypothesized that APC may regulate intracellular [Ca2+] flux in human brain endothelial cells (BECs) via EPCR and PAR-1. Primary cortical BECs derived from human autopsies (early passage) and HUVECs were used for [Ca2+]i imaging fluorometry. Cells were exposed for 1 minute to APC, protein C zymogen, or mutant Ser360Ala-APC, and [Ca2+]i was monitored in the presence or absence of antibodies against PAR-1, PAR-2, PAR-3, or EPCR. APC, but not protein C zymogen or the active site mutant Ser360Ala-APC, induced dose-dependent [Ca2+]i release in human BECs ( [Ca2+]i max = 278.3 ± 19.5 nM; EC50 for APC = 0.23 ± 0.02 nM, n = 70 measurements). APC-induced [Ca2+]i signaling was abolished by a cleavage site blocking antiPAR-1 antibody, whereas antiPAR-2 and PAR-3 antibodies were without effect. Antibody RCR252 that ablates APC binding to EPCR blocked APC-mediated [Ca2+]i signaling, whereas anti-EPCR antibody RCR92 that does not block APC binding did not abolish the APC-induced [Ca2+]i response. Experiments using HUVECs confirmed the findings for BECs. Thapsigargin inhibited the APC-induced [Ca2+]i signal, implicating the endoplasmic reticulum as a major source for the APC-induced [Ca2+]i release. These data suggest that APC regulates [Ca2+]i in human brain endothelium and in HUVECs by binding to EPCR and signaling via PAR-1.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
Y. Wang, M. Thiyagarajan, N. Chow, I. Singh, H. Guo, T. P. Davis, and B. V. Zlokovic
Differential Neuroprotection and Risk for Bleeding From Activated Protein C With Varying Degrees of Anticoagulant Activity
Stroke,
May 1, 2009;
40(5):
1864 - 1869.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. J. S. Preston, S. Tran, J. A. Johnson, F. N. Ainle, S. Harmon, B. White, O. P. Smith, P. V. Jenkins, B. Dahlback, and J. S. O'Donnell
Platelet Factor 4 Impairs the Anticoagulant Activity of Activated Protein C
J. Biol. Chem.,
February 27, 2009;
284(9):
5869 - 5875.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Thiyagarajan, J. A. Fernandez, S. M. Lane, J. H. Griffin, and B. V. Zlokovic
Activated Protein C Promotes Neovascularization and Neurogenesis in Postischemic Brain via Protease-Activated Receptor 1
J. Neurosci.,
November 26, 2008;
28(48):
12788 - 12797.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Harmon, R. J. S. Preston, F. N. Ainle, J. A. Johnson, M. S. Cunningham, O. P. Smith, B. White, and J. S. O'Donnell
Dissociation of Activated Protein C Functions by Elimination of Protein S Cofactor Enhancement
J. Biol. Chem.,
November 7, 2008;
283(45):
30531 - 30539.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Danielyan, K. Ganguly, B.-S. Ding, D. Atochin, S. Zaitsev, J.-C. Murciano, P. L. Huang, S. E. Kasner, D. B. Cines, and V. R. Muzykantov
Cerebrovascular Thromboprophylaxis in Mice by Erythrocyte-Coupled Tissue-Type Plasminogen Activator
Circulation,
September 30, 2008;
118(14):
1442 - 1449.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Schouten, W. J. Wiersinga, M. Levi, and T. van der Poll
Inflammation, endothelium, and coagulation in sepsis
J. Leukoc. Biol.,
March 1, 2008;
83(3):
536 - 545.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. O. Mosnier, B. V. Zlokovic, and J. H. Griffin
The cytoprotective protein C pathway
Blood,
April 15, 2007;
109(8):
3161 - 3172.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Thiyagarajan, T. Cheng, and B. V. Zlokovic
Endothelial Cell Protein C Receptor: Role Beyond Endothelium?
Circ. Res.,
February 2, 2007;
100(2):
155 - 157.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Bretschneider, B. Uzonyi, A.-A. Weber, J. W. Fischer, R. Pape, K. Lotzer, and K. Schror
Human Vascular Smooth Muscle Cells Express Functionally Active Endothelial Cell Protein C Receptor
Circ. Res.,
February 2, 2007;
100(2):
255 - 262.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Feistritzer, R. A. Schuepbach, L. O. Mosnier, L. A. Bush, E. Di Cera, J. H. Griffin, and M. Riewald
Protective Signaling by Activated Protein C Is Mechanistically Linked to Protein C Activation on Endothelial Cells
J. Biol. Chem.,
July 21, 2006;
281(29):
20077 - 20084.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Dahlback and B. O. Villoutreix
Regulation of Blood Coagulation by the Protein C Anticoagulant Pathway: Novel Insights Into Structure-Function Relationships and Molecular Recognition
Arterioscler Thromb Vasc Biol,
July 1, 2005;
25(7):
1311 - 1320.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Riewald and W. Ruf
Protease-activated Receptor-1 Signaling by Activated Protein C in Cytokine-perturbed Endothelial Cells Is Distinct from Thrombin Signaling
J. Biol. Chem.,
May 20, 2005;
280(20):
19808 - 19814.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Steinhoff, J. Buddenkotte, V. Shpacovitch, A. Rattenholl, C. Moormann, N. Vergnolle, T. A. Luger, and M. D. Hollenberg
Proteinase-Activated Receptors: Transducers of Proteinase-Mediated Signaling in Inflammation and Immune Response
Endocr. Rev.,
February 1, 2005;
26(1):
1 - 43.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. L. Contreras, C. Eckstein, C. A. Smyth, G. Bilbao, M. Vilatoba, S. E. Ringland, C. Young, J. A. Thompson, J. A. Fernandez, J. H. Griffin, et al.
Activated Protein C Preserves Functional Islet Mass After Intraportal Transplantation: A Novel Link Between Endothelial Cell Activation, Thrombosis, Inflammation, and Islet Cell Death
Diabetes,
November 1, 2004;
53(11):
2804 - 2814.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. O. Mosnier, A. J. Gale, S. Yegneswaran, and J. H. Griffin
Activated protein C variants with normal cytoprotective but reduced anticoagulant activity
Blood,
September 15, 2004;
104(6):
1740 - 1744.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Uchiba, K. Okajima, Y. Oike, Y. Ito, K. Fukudome, H. Isobe, and T. Suda
Activated Protein C Induces Endothelial Cell Proliferation by Mitogen-Activated Protein Kinase Activation In Vitro and Angiogenesis In Vivo
Circ. Res.,
July 9, 2004;
95(1):
34 - 41.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|